A New Approach to the Development of Disease-Modifying Therapies for PD

Mov Disord. 2021 May;36(5):1281. doi: 10.1002/mds.28589.
No abstract available

Keywords: Parkinson's disease; clinical trial; disease modifying; neuroprotection.

Publication types

  • Letter
  • Comment

MeSH terms

  • Humans
  • Neuroprotective Agents*
  • Pandemics
  • Parkinson Disease*

Substances

  • Neuroprotective Agents